Dissecting Age-Stratified Immunity to Different Dengue Virus Serotypes and Zika Viruses Among Children in a Highly Endemic Region in Sri Lanka

Le résumé fourni par la source

Abstract Background Determining serotype-specific age stratified dengue (DENV) and Zika (ZIKV) seroprevalence rates is crucial for implementing vaccines and vector control strategies. Therefore, we sought to assess age-stratified seroprevalence of monotypic or multi-typic exposure in a community cohort in Sri Lanka. Methods The DENV-specific serostatus was assessed in 4,161 children aged 4 to 16 years, using an in-house DENV specific IgG ELISA and compared the results with a widely used commercial assay (dengue indirect Panbio IgG ELISA). We also used a multiplexed, microsphere-based serological assay, to characterise monotypic vs multi-typic infections and to differentiate exposure rates to different DENV serotypes and ZIKV in a sub-cohort of children (n=604). Results By IgG-ELISA DENV seropositivity was 72.34% (n=4,161), and the seroprevalence rate significantly increased with age (Spearman’s r=1.0, p=0.003). The estimated FOI was 0.16 (95% credible interval 0.14–0.17). Of the 604 individuals tested by Luminex, 258 (42.7%) had a monotypic dengue infection, whereas 209 (34.9%) had a multi-typic response. 100 (16.5%) had evidence of a past infection to zika, while 20 (3.33%) children, only had antibodies to the ZIKV. Of the 258 individuals with evidence of a monotypic infection of DENV, DENV2 (56.83%) and DENV1 (30.57%) accounted for most infections. An inverse correlation between exposure to ZIKV and age (Spearmans’s r=-0.72, 0=0.007). Conclusions 72.3% of children were seropositive for dengue with 42.7% been infected with only one DENV in the past. The data suggests that prior immunity to DENV may reduce the risk of ZIKV infection, which should be further assessed.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.